Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Controlled radial artery access site model with protamine reversal
2012-005410-19Phase 4Terminated
- Sponsor
- Jessa Hospital
- Start
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of protamine in cardiac morbidity and None, sponsored by Jessa Hospital. Primary endpoint: Time to hemostasis at radial artery access site. Started Feb 2013; status: terminated.
02
Drugs
protamine
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2012-005410-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005410-19.